These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21865412)

  • 21. Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population.
    Cocco E; Sardu C; Murru R; Frau J; Lorefice L; Mamusa E; Contu P; Marrosu MG
    Mult Scler; 2009 Sep; 15(9):1030-6. PubMed ID: 19625333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender effects in relapsing-remitting multiple sclerosis: correlation between clinical variables and gene expression molecular pathways.
    Achiron A; Gurevich M
    J Neurol Sci; 2009 Nov; 286(1-2):47-53. PubMed ID: 19596127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Late onset multiple sclerosis].
    Delalande S; De Seze J; Ferriby D; Stojkovic T; Vermersch P
    Rev Neurol (Paris); 2002 Nov; 158(11):1082-7. PubMed ID: 12451340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical-epidemiological characteristics of late onset multiple sclerosis].
    Gómez-García AO; Fernández-Concepción O; Milán-Ginjauma E
    Rev Neurol; 1997 Dec; 25(148):1863-6. PubMed ID: 9528018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis.
    Tremlett H; van der Mei IA; Pittas F; Blizzard L; Paley G; Mesaros D; Woodbaker R; Nunez M; Dwyer T; Taylor BV; Ponsonby AL
    Neuroepidemiology; 2008; 31(4):271-9. PubMed ID: 18971584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.
    Debouverie M; Laforest L; Van Ganse E; Guillemin F;
    Mult Scler; 2009 Feb; 15(2):251-7. PubMed ID: 19181774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis.
    Ceccarelli A; Rocca MA; Perego E; Moiola L; Ghezzi A; Martinelli V; Comi G; Filippi M
    Mult Scler; 2011 Jun; 17(6):702-7. PubMed ID: 21228024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with the risk of secondary progression in multiple sclerosis.
    Koch M; Uyttenboogaart M; van Harten A; De Keyser J
    Mult Scler; 2008 Jul; 14(6):799-803. PubMed ID: 18573840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and radiological study of Iraqi multiple sclerosis patients with childhood onset.
    Hasan ZN; Hasan HA; Sabah AS
    Neurosciences (Riyadh); 2011 Jul; 16(3):229-32. PubMed ID: 21677612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children.
    Boiko AN; Guseva ME; Guseva MR; Boiko SY; Sudomoina MA; Bikova OV; Maslova OI; Favorova OO; Gusev EI
    J Neurovirol; 2000 May; 6 Suppl 2():S152-5. PubMed ID: 10871804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.
    Kremenchutzky M; Rice GP; Baskerville J; Wingerchuk DM; Ebers GC
    Brain; 2006 Mar; 129(Pt 3):584-94. PubMed ID: 16401620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
    Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
    Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor recovery after the first two attacks of multiple sclerosis is associated with poor outcome five years later.
    Scott TF; Schramke CJ
    J Neurol Sci; 2010 May; 292(1-2):52-6. PubMed ID: 20202650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Young-onset multiple sclerosis].
    Silva A; Sá MJ
    Rev Neurol; 1999 Jun 1-15; 28(11):1036-40. PubMed ID: 10390767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study.
    Saida T; Tashiro K; Itoyama Y; Sato T; Ohashi Y; Zhao Z;
    Neurology; 2005 Feb; 64(4):621-30. PubMed ID: 15728282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis.
    Healy BC; Engler D; Gholipour T; Weiner H; Bakshi R; Chitnis T
    J Neurol Sci; 2011 Apr; 303(1-2):109-13. PubMed ID: 21251671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sclerosis in Pakistan.
    Wasay M; Ali S; Khatri IA; Hassan A; Asif M; Zakiullah N; Ahmed A; Malik A; Khealani B; Haq A; Fredrikson S
    Mult Scler; 2007 Jun; 13(5):668-9. PubMed ID: 17548448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sibling disability risk at onset and during disease progression in familial multiple sclerosis.
    Wellek A; Korsukewitz C; Bach JP; Schock S; Eienbröker C; Seitz F; Spengler A; Hemmer B; Schlegel K; Oertel WH; Sommer N; Tackenberg B
    Mult Scler; 2011 Sep; 17(9):1060-6. PubMed ID: 21561958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The natural history of multiple sclerosis with childhood onset.
    Renoux C; Vukusic S; Confavreux C
    Clin Neurol Neurosurg; 2008 Nov; 110(9):897-904. PubMed ID: 18534742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relapse severity and recovery in early pediatric multiple sclerosis.
    Fay AJ; Mowry EM; Strober J; Waubant E
    Mult Scler; 2012 Jul; 18(7):1008-12. PubMed ID: 22183939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.